A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia
Status:
Recruiting
Trial end date:
2023-03-14
Target enrollment:
Participant gender:
Summary
Randomized phase 3 trial to compare efficacy and safety of oral fosfomycin versus
ciprofloxacin to prevent febrile neutropenia in patients with acute leukemia or recipients of
hematopoietic stem cell transplant.
Phase:
Phase 3
Details
Lead Sponsor:
Fundación para la Investigación Biosanitaria del Principado de Asturias
Collaborators:
Instituto de Investigación Marqués de Valdecilla Instituto de Salud Carlos III